Lyra Therapeutics Reports Positive Topline Results From BEACON Phase 2 Study Of LYR-220

Biotechnology company Lyra Therapeutics, Inc. (LYRA) announced Tuesday positive topline results from the BEACON Phase 2 clinical study of LYR-220 in adult patients with CRS, with and without polyps, who have had prior ethmoid sinus surgery.

Related Keywords

California ,United States ,Sheng Kee ,Morgan Stanley ,Retailer Kohl Corp ,Drug Administration ,California Inc ,Tesla Inc ,Retailer Kohl ,Magic Mixies Genie Lamp ,Magic Whispers Lune ,Little Live Pets My Puppy ,Disney Princess Royal Adventures Castle ,Treasure Chest ,Mooncake Gift Boxes ,Assorted Mooncake Gift Box ,Assorted Mooncake Tin Gift Box ,Lyra Therapeutics ,Kyra ,Iotechnology Company Lyra ,Eacon Phase 2 Clinical Study ,Lyr 220 ,Thmoid Sinus Surgery ,